In the remaining 6 cases, the hematological abnormality was finally classified as secondary erythrocytosis (patients E9-E14) due to kidney cancer with increased endogenous EPO levels (patient E9) and chronic obstructive pulmonary disease (COPD, 5 patients: E10-E14). This evidence concerns the gene EPO and kidney cancer.